[A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders]

Acta Psychiatr Belg. 1975 May;75(3):320-33.
[Article in French]

Abstract

After a preliminary encouraging trial of mepiprazol (EMD 16.923) on 8 patients, a double-blind cross-over study of mepiprazol and diazepam was performed in order to compare their effect in the treatment of neurotic disorders, particularly on various forms of anxiety.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Anxiety Disorders / drug therapy
  • Clinical Trials as Topic
  • Diazepam / adverse effects
  • Diazepam / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurotic Disorders / drug therapy*
  • Piperazines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Self-Assessment
  • Tranquilizing Agents / therapeutic use*

Substances

  • Piperazines
  • Pyrazoles
  • Tranquilizing Agents
  • Diazepam